key: cord-0725064-bjxbuoqt
authors: Shen, B.; Hoshmand-Kochi, M.; Abbasi, A.; Glass, S.; Jiang, Z.; Singer, A. J.; Thode, H. C.; Li, H.; Hou, W.; Duong, T. Q.
title: Initial chest radiograph scores inform COVID-19 status, intensive care unit admission and need for mechanical ventilation
date: 2021-02-18
journal: Clin Radiol
DOI: 10.1016/j.crad.2021.02.005
sha: ae84df6e46c8146d89c039e5d4a36bbb83b7be31
doc_id: 725064
cord_uid: bjxbuoqt

Aim To evaluate whether portable chest radiography (CXR) scores are associated with coronavirus disease 2019 (COVID-19) status and various clinical outcomes. Materials and methods This retrospective study included 500 initial CXR from COVID-19-suspected patients. Each CXR was scored based on geographic extent and degree of opacity as indicators of disease severity. COVID-19 status and clinical outcomes including intensive care unit (ICU) admission, mechanical ventilation, mortality, length of hospitalisation, and duration on ventilator were collected. Multivariable logistic regression analysis was performed to evaluate the relationship between CXR scores and COVID-19 status, CXR scores and clinical outcomes, adjusted for code status, age, gender and co-morbidities. Results The interclass correlation coefficients amongst raters were 0.94 and 0.90 for the extent score and opacity score, respectively. CXR scores were significantly (p<0.01) associated with COVID-19 positivity (odd ratio [OR] = 1.49; 95% confidence interval [CI]: 1.27–1.75 for extent score and OR=1.75; 95% CI: 1.42–2.15 for opacity score), ICU admission (OR=1.19; 95% CI: 1.09–1.31 for extent score and 1.26; 95% CI: 1.10–1.44 for opacity score), and invasive mechanical ventilation (OR=1.22; 95% CI: 1.11–1.35 for geographic score and 1.21; 95% CI: 1.051.38 for opacity score). CXR scores were not significantly different between survivors and non-survivors after adjusting for code status (p>0.05). CXR scores were not associated with length of hospitalisation or duration on ventilation (p>0.05). Conclusions Initial CXR scores have prognostic value and are associated with COVID-19 positivity, ICU admission, and mechanical ventilation.

Coronavirus disease 2019 (COVID-19), an infectious disease that can cause severe respiratory illness (1) (2) (3) , has already infected 13 million people and killed more than 570,000 worldwide (4). COVID-19 continues to strain resources in many hospitals around the world. Lung imaging plays an important role in the management of J o u r n a l P r e -p r o o f patients during COVID-19 pandemic. Although reverse transcription polymerase chain reaction (RT-PCR) of a nasopharyngeal or oropharyngeal swab specimen is a reference standard (3, 5) for diagnosing COVID-19 infection, it has a long turnaround time and high false-negative rate (6) . Newer tests, such as the lateral flow tests, have rapid turnaround time, but low sensitivity (7) . Computed tomography (CT) (8) was used in China early on in the pandemic when RT-PCR was less reliable, and CT offers high sensitivity and faster turnaround time; however, CT is prone to crosscontamination and, thus, it is not widely used in the context of COVID-19 in the United States and elsewhere in the world. In addition, CT is not readily accessible in many parts of the world and poses the risk of radiation exposure to patients. By contrast, chest radiography (CXR) is convenient and can be readily disinfected between uses, is more accessible, and has a lower radiation dose than CT, although it has lower sensitivity than CT. Nonetheless, CXRs show characteristic ground-glass opacities and/or consolidation in the lungs associated with COVID-19 infection (9) .

CXR is often one of the very first clinical assessments that suspected COVID-19 patients receive. Under the appropriate context and along with other clinical assessment, CXR can facilitate diagnosis and triage patients while RT-PCR results are pending. CXR is also well suited to monitor disease progression during hospitalisation, such as sicker patients in the ICU, which is very crucial ast hose patients cannot be readily moved to the CT machine.

To date, CXR score has not been widely used for staging of disease severity of COVID-19 lung infection in clinical practice. Although a few recent studies have related initial CXR scores of COVID-19 patients to various clinical outcomes, such as J o u r n a l P r e -p r o o f ICU admission, need for mechanical ventilation, mortality, length of hospitalisation, and duration on ventilator (10) (11) (12) (13) (14) , the results are inconsistent and controversial. The CXR scoring methods varied, and demographics and comorbidities were accounted for in some but not other studies. No studies to date have accounted for whether patients were removed from aggressive therapies due to having a "do not resuscitate" order (i.e., code status), which confound data interpretation and compromise the prognostic value of CXR scores. As such, the potential of CXR to stage disease severity of COVID-19 lung infection is not yet fully realised.

The goal of this study was to further investigate the association of CXR scores of disease severity with COVID-19 status, ICU admission, need for mechanical ventilation, mortality, length of hospitalisation, and duration on ventilator. The types of CXR scores were established carefully for disease severity, one based on geographical extent of involvement and the other based on degree of opacity, with consensus amongst a group of chest radiologists and residents. Analysis accounted for patients' code status, demographics, and co-morbidities.

This is an institutional review board approved retrospective study from University 

To establish the disease severity score, a group of four board-certified chest radiologists of 10-20 years of experience and two radiology residents in training worked together to reach consensus by evaluating 12 images of portable CXRs of J o u r n a l P r e -p r o o f COVID-19 patients, which was part of the 500 CXRs. The same chest radiologists and residents scored the 500 CXRs for disease severity using the following criteria based on geographical extent and degree of opacity. The extent score of 0-4 was assigned to each of the right and left lungs depending on the extent of involvement with ground glass opacities or consolidation: 0 = no involvement; 1 = <25%; 2 = 25-50%; 3 = 51-75%; 4 = >75% involvement. The opacity score of 0-4 was assigned to each of the right and left lungs as: 0 = no opacity; 1 = ground glass opacity; 2 = mix of consolidation and ground glass opacity (<50% consolidation); 3 = mix of consolidation and ground glass opacity (>50% consolidation); 4 = complete whiteout. The right and left lung were scored separately and added together. In short, extent score ranged from 0-8, the opacity score ranged from 0-8. In addition, the sum of these two types of scores (0-16) and the product of the two types of scores (0-64) were computed. To minimise bias, the raters were blinded to the clinical data while scoring the CXRs. Each CXR was scored by two raters independently and the mean of the scores of two raters were calculated.

Statistical analysis was performed with IBM SPSS software (Chicago, IL, USA).

Intraclass correlation coefficient was calculated to assess inter-reader agreement of the CXR scores. Means and standard deviations of extent score, opacity score, sum of extent and opacity score, product of extent and opacity score were calculated.

Multivariable logistic regression analysis were performed to analyse the relationships between CXR scores with ICU admission, mortality, need for ventilation, and gender.

Odds ratios were also computed. Linear regression analysis was performed to analyse the correlation between CXR scores and age, length of hospital stay, and duration on ventilation. A p<0.05 is taken to be statistically significant unless otherwise specified. The extent score, opacity score, sum of extent and opacity score, product of extent and opacity score scores were significantly higher in COVID-19 positive patients compared to COVID-19 negative patients, with the odd ratios ranging from 1.08 to 1.75 after adjusting for age, sex and co-morbidities (Table 2) .

CXR scores were significantly higher in ICU patients than in regular ward patients, with the odd ratios ranging from 1.04 to 1.26 after adjusting for age, sex and comorbidities (Table 3a) . CXR scores were also significantly higher in patients on invasive mechanical ventilators than in patients not on ventilators, with the odd ratios ranging from 1.03 to 1.22 after adjusting for age, sex, and co-morbidities (Table 3b ).

The majority of the ICU patients (85%) were on invasive mechanical ventilators.

For the general floor admission cohort, all CXR scores were significantly higher in non-survivors than in survivors with the odd ratios ranging from 1.09 to 2.18, after adjusting for age, sex, and co-morbidities (Table 4a) . For the ICU cohort, opacity score, sum of extent, and opacity score, and product of extent and opacity score were significantly higher in non-survivors than in survivors with the odds ratios ranging from 1.04 to 1.38, after adjusting for age, sex and co-morbidities, but not the extent score (Table 4b) .

Mortality with respect to the patient's code status was also analysed. Amongst the regular ward patients, 91% of the survivors and 7% of the non-survivors were full code, which indicates all resuscitation interventions to be performed. Amongst the ICU patients, 93% of the survivors and 27% of the non-survivors were full code. CXR J o u r n a l P r e -p r o o f scores between survivors and non-survivors in ICU who were full code were not significantly different (Table 4c ). There were only two non-survivors on the general floor who were full code, and they were not further analysed.

CXR scores were not associated with the length of hospital stay both for the regular ward patients (R=0.04 for extent score and R=0.12 for opacity score, p>0.05) and the ICU patients (R=-0.01 for extent score and R=-0.18 for opacity score, p>0.05) when regular patients and ICU patients were analysed separately; however, the extent score correlated weakly with the length of hospital stay when regular ward patients and ICU patients were analysed together (R=0.13, p<0.05) while the opacity score was not (R=0.08, p>0.05). CXR scores were not associated with the duration on ventilator either (R=0.02 for geographic score and R=0.03 for opacity score, p>0.05).

The extent score correlated weakly with duration of symptoms prior to ED visit (R=0.11, p<0.05) while the opacity score was not (R=0.09, p>0.05). There were no association of CXR scores with age (p>0.05) or sex (p>0.05).

This study investigated whether the initial CXR scores inform COVID-19 status, ICU admission, need for ventilation, mortality, length of hospitalisation, and duration on ventilator. CXR scores were found to be associated with COVID-19 status, ICU admission, need for ventilation, but not with mortality after accounting for code status, length of hospitalisation, or duration on ventilator. A unique CXR scoring system was used in the present study. Different CXR scoring systems have been used to evaluate COVID-19 lung infection, some more sophisticated and some J o u r n a l P r e -p r o o f simpler (10) (11) (12) (13) (14) (15) . The RALE score, which is more sophisticated, is based on the sum of product of geographical extent and degree of opacity from different lung zones, and has been used to evaluate for severity of lung oedema (16) and adopted to score CXR in evaluating COVID-19 lung infection (13, 14) . Several other simpler scoring systems did not take degree of opacity into consideration (10, 11, 15) . The present scoring system also used both geographic extent and degree of opacity, but to make the system simpler, the lungs were not divided into different zones. The scoring system is relatively easy to use, has a reasonable dynamic range, and has high inter-rater agreement. Interestingly, the extent score and opacity score were highly correlated. The opacity scores generally yielded higher odds ratios than extent scores for clinical outcomes. This suggests that opacity (consolidation) likely reflects disease severity better than the extent of lung infection. This is consistent with CXR and CT findings showing COVID-19 pneumonia progressing from ground-glass opacity to consolidation (9, 17) . The sum and product of the two scores was also investigated. The rationale for using the sum of the score is that the two scores were independently scored, and it is possible that their linear combination could add information. The rationale for using the product of the two scores is that it is possible that their geometric weighted average (extent and magnitude of opacity) could add information when combined linearly together. It is not clear whether individual scores, linear combination, or geometric combination yielded better results. Surprisingly, the sum and product of the two scores yielded similar conclusions, but did not yielded better odds ratios than individual scores alone, suggesting that they might not add value. It would be useful to have a CXR reporting template that can be employed A notable finding is that the initial CXR scores were not associated with mortality after adjusted for code status. Previous studies (10-15) did not account for code status. As a result, it is challenging to determine whether patients who died would have survived if more aggressive measures had been taken among patients assigned to comfort care only. Similarly, no correlations were found between initial CXR scores and length of hospital stay for regular ward patients or ICU patients, and between initial CXR scores and duration on mechanical ventilator. These findings are not surprising because these outcomes are far downstream from the patients' status in the ED, although such an association might exist depending on patient cohorts.

The present results are consistent with Toussie et al. who reported CXR scores were not associated with length of hospital stay (11), but inconsistent with Kim et al. who reported CXR scores were associated with length of hospital stay (10) . Possible explanations for this discrepancy could be due to differences in patient cohort.

Interestingly, there was a weak correlation between the extent score and length of hospital stay when combining regular ward and ICU patients, but did not find a correlation when analysing regular ward and ICU patients separately. One possible explanation is that ICU patients tend to have higher CXR scores and longer length of hospitalisation than regular ward patients.

This study has several limitations. First, although the present CXR score system is easy to use with good inter-rater agreement, there are more sophisticated score schemes that could reflect disease severity better (13, 14) . Second, the present study used only initial CXRs. Longitudinal CXR scoring is needed to better inform clinical trajectory and outcome. Third, although several co-morbidities were included in the study, body mass index (BMI) was not included, which is a known risk factor for COVID-19. Fourth, although the majority of the CXRs (90%) were acquired on the day of ED presentation and presumably before the patients received interventions, it was hard to track whether the patients received interventions prior to CXR acquisition, which could have affected the CXR scores. Finally, this is a retrospective study from a single institution. These findings need to be repeated using multiple institutional data to test generalisability.

In conclusion, initial CXR scores in the ED are associated with positive COVID-19 status, ICU admission, and need for invasive mechanical ventilation. Initial 

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -the latest 2019 novel coronavirus outbreak in Wuhan, China

Detection of SARS-CoV-2 in different types of clinical specimens

Laboratory diagnosis of COVID-19: current issues and challenges

Negative nasopharyngeal swabs early in the course of COVID-19

Covid-19: lateral flow tests miss over half of cases, Liverpool pilot data show

Imaging and clinical features of patients with

novel coronavirus SARS-CoV-2

Portable chest X-ray in coronavirus disease-19 (COVID-19): a pictorial review

The role of initial chest X-ray in triaging patients with suspected COVID-19 during the pandemic

Clinical and chest radiography features determine patient outcomes in young and middle age adults with COVID-19

Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy

Chest X-ray in new coronavirus disease 2019 (COVID-19) infection: findings and correlation with clinical outcome

Clinical utility of chest radiography for severe COVID-19

Frequency and distribution of chest radiographic findings in COVID-19 positive patients

Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS

Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection

Prognostic value of C-reactive protein in patients with COVID-19

• Initial CXR scores are associated with COVID-19 status

• Initial CXR scores are associated with ICU admission and need for mechanical ventilation

• Initial CXR could help identify high risk patients, triage and manage COVID-19 patients

J o u r n a l P r e -p r o o f

x The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f